CTX leaves a critical gap in the body’s bile acid levels. CTEXLI helps replenish bile acid levels.

HELPS
PUT BACK
WHAT CTX
TAKES AWAY

CTEXLI is the only FDA-approved treatment for cerebrotendinous xanthomatosis (CTX) in adults. Talk to a health care provider to learn more about CTEXLI.

CTEXLI is designed to help stop the buildup of CTX toxins

Learn How It Works

Lower levels of toxins were achieved in participants taking CTEXLI vs those who took placebo

See the Results

CTEXLI has an established FDA-approved safety profile

View Safety

Receive more information about CTEXLI

Getting started on CTEXLI is simple with Mirum Access Plus

Learn About Mirum Access Plus

INDICATION

CTEXLI is indicated for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.

IMPORTANT SAFETY INFORMATION

What are the possible side effects of CTEXLI?

Serious Side Effects—Hepatotoxicity (Liver Injury): You will need to undergo laboratory testing before starting and periodically while on treatment with CTEXLI to assess liver function. Changes in certain liver tests may occur during treatment and may be a sign of liver injury. People with preexisting liver disease or bile duct abnormalities may be at higher risk for liver injury during treatment. Stop taking CTEXLI immediately and tell your healthcare provider right away if you get any signs or symptoms of liver problems, including:
- Stomach (abdomen) pain
- Bruising
- Dark-colored urine
- Feeling tired (fatigue)
- Bleeding
- Yellowing of the skin and eyes
- Nausea
- Itching
Most Common Side Effects: Diarrhea, headache, stomach pain, constipation, high blood pressure, muscular weakness, and upper respiratory tract infection.

Tell your healthcare provider about all the medications that you take, as CTEXLI may interact with other medicines. Do not take bile acid sequestering agents or aluminum-based antacids with CTEXLI. If you take coumarin, your doctor will need to monitor your prothrombin time (PT) while taking CTEXLI and may adjust your coumarin dose.

Your healthcare provider may temporarily or permanently stop treatment if you have certain side effects.

CTEXLI is taken by mouth three (3) times each day and can be taken with or without food. Swallow tablets whole.

These are not all the possible side effects of CTEXLI. For more information, ask your healthcare provider or pharmacist. Tell your doctor if you have any side effect that bothers you or that does not go away.

You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Mirum Pharmaceuticals at 1-855-MRM-4YOU (1-855-676-4968).

Please see accompanying full Prescribing Information.

INDICATION

CTEXLI is indicated for the treatment of cerebrotendinous xanthomatosis (CTX) in adults.

IMPORTANT SAFETY INFORMATION

What are the possible side effects of CTEXLI?

Serious Side Effects—Hepatotoxicity (Liver Injury): You will need to undergo laboratory testing before starting and periodically while on treatment with CTEXLI to assess liver function. Changes in certain liver tests may occur during treatment and may be a sign of liver injury. People with preexisting liver disease or bile duct abnormalities may be at higher risk for liver injury during treatment. Stop taking CTEXLI immediately and tell your healthcare provider right away if you get any signs or symptoms of liver problems, including:
- Stomach (abdomen) pain
- Bruising
- Dark-colored urine
- Feeling tired (fatigue)
- Bleeding
- Yellowing of the skin and eyes
- Nausea
- Itching
Most Common Side Effects: Diarrhea, headache, stomach pain, constipation, high blood pressure, muscular weakness, and upper respiratory tract infection.

Your healthcare provider may temporarily or permanently stop treatment if you have certain side effects.

CTEXLI is taken by mouth three (3) times each day and can be taken with or without food. Swallow tablets whole.

You may report side effects to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Mirum Pharmaceuticals at 1-855-MRM-4YOU (1-855-676-4968).

Please see accompanying full Prescribing Information.

HELPSPUT BACKWHAT CTXTAKES AWAY

Getting started on CTEXLI is simple with Mirum Access Plus

INDICATION

IMPORTANT SAFETY INFORMATION

INDICATION

IMPORTANT SAFETY INFORMATION

HELPS
PUT BACK
WHAT CTX
TAKES AWAY